What is the address of Dokter Charlotte Smetcoren, Neurologie?

The registered office of Dokter Charlotte Smetcoren, Neurologie is located at Bronstraat 37, 1652 Beersel.

Is Dokter Charlotte Smetcoren, Neurologie still active?

Yes. According to the CBE (17 September 2026) Dokter Charlotte Smetcoren, Neurologie is active, legal situation “Normale toestand”, started on 25 September 2019.

Is Dokter Charlotte Smetcoren, Neurologie registered on Peppol?

Yes, Dokter Charlotte Smetcoren, Neurologie is registered on the Peppol network with ID 0208:0734906642.

What is the enterprise number of Dokter Charlotte Smetcoren, Neurologie?

The enterprise number of Dokter Charlotte Smetcoren, Neurologie is BE0734906642.

When was Dokter Charlotte Smetcoren, Neurologie founded?

Dokter Charlotte Smetcoren, Neurologie was founded on 25 September 2019.

Who are the directors of Dokter Charlotte Smetcoren, Neurologie?

According to the 2025 annual accounts, the directors of Dokter Charlotte Smetcoren, Neurologie are: Charlotte Smetcoren.

Is Dokter Charlotte Smetcoren, Neurologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 September 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dokter Charlotte Smetcoren, Neurologie make in 2025?

Dokter Charlotte Smetcoren, Neurologie posted a profit after taxes of € 188,084 in financial year 2025.

What is the revenue of Dokter Charlotte Smetcoren, Neurologie?

As a small company, Dokter Charlotte Smetcoren, Neurologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 249,755.

Dokter Charlotte Smetcoren, Neurologie (Private Limited)

Dossier Dokter Charlotte Smetcoren, Neurologie, printed on 17 September 2026 from databakkes.be/en/0734906642/dokter-charlotte-smetcoren-neurologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dokter Charlotte Smetcoren, Neurologie from Beersel, company number BE0734906642, closed financial year 2025 with a result of € 188,084 after tax. For that financial year Dokter Charlotte Smetcoren, Neurologie recorded a gross margin of € 249,755 and equity of € 287,888. Compared with financial year 2024, the result moved from € 93,565 to € 188,084. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Growing

€ 287,888

▲ 188% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 188,084

▲ 101% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 33,915

▼ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 281,888.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 2,769

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,425

▲ € 1,210 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 93,154 Gross margin 2022: € 93,154 First fiscal year in the series	€ 91,985 Gross margin 2023: € 91,985 ▼ 1% vs 2022 (€ 93,154) Unfavourable step	€ 123,720 Gross margin 2024: € 123,720 ▲ 35% vs 2023 (€ 91,985) Favourable step	€ 249,755 Gross margin 2025: € 249,755 ▲ 102% vs 2024 (€ 123,720) Favourable step	▲ 102%
Profit after taxes	€ 71,201 Profit after taxes 2022: € 71,201 First fiscal year in the series	€ 69,901 Profit after taxes 2023: € 69,901 ▼ 2% vs 2022 (€ 71,201) Unfavourable step	€ 93,565 Profit after taxes 2024: € 93,565 ▲ 34% vs 2023 (€ 69,901) Favourable step	€ 188,084 Profit after taxes 2025: € 188,084 ▲ 101% vs 2024 (€ 93,565) Favourable step	▲ 101%
Equity	€ 268,985 Equity 2022: € 268,985 First fiscal year in the series	€ 221,239 Equity 2023: € 221,239 ▼ 18% vs 2022 (€ 268,985) Unfavourable step	€ 99,804 Equity 2024: € 99,804 ▼ 55% vs 2023 (€ 221,239) Unfavourable step	€ 287,888 Equity 2025: € 287,888 ▲ 188% vs 2024 (€ 99,804) Favourable step	▲ 188%
Total debts	€ 9,183 Total debts 2022: € 9,183 First fiscal year in the series	€ 6,790 Total debts 2023: € 6,790 ▼ 26% vs 2022 (€ 9,183) Favourable step	€ 119,215 Total debts 2024: € 119,215 ▲ € 112,425 vs 2023 (€ 6,790) Unfavourable step	€ 4,785 Total debts 2025: € 4,785 ▼ 96% vs 2024 (€ 119,215) Favourable step	▼ 96%
Cash	€ 168,869 Cash 2022: € 168,869 First fiscal year in the series	€ 107,846 Cash 2023: € 107,846 ▼ 36% vs 2022 (€ 168,869) Unfavourable step	€ 49,792 Cash 2024: € 49,792 ▼ 54% vs 2023 (€ 107,846) Unfavourable step	€ 33,915 Cash 2025: € 33,915 ▼ 32% vs 2024 (€ 49,792) Unfavourable step	▼ 32%
Retained profit	€ 262,985 Retained profit 2022: € 262,985 First fiscal year in the series	€ 215,239 Retained profit 2023: € 215,239 ▼ 18% vs 2022 (€ 262,985) Unfavourable step	€ 93,804 Retained profit 2024: € 93,804 ▼ 56% vs 2023 (€ 215,239) Unfavourable step	€ 281,888 Retained profit 2025: € 281,888 ▲ 201% vs 2024 (€ 93,804) Favourable step	▲ 201%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 117,647 Dividend 2023: € 117,647 Unchanged (€ 0) Unchanged	€ 215,000 Dividend 2024: € 215,000 ▲ 83% vs 2023 (€ 117,647) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 215,000) Unchanged	▼ 100%
Balance sheet total	€ 278,168 Balance sheet total 2022: € 278,168 First fiscal year in the series	€ 228,030 Balance sheet total 2023: € 228,030 ▼ 18% vs 2022 (€ 278,168) Unchanged	€ 219,019 Balance sheet total 2024: € 219,019 ▼ 4% vs 2023 (€ 228,030) Unchanged	€ 292,673 Balance sheet total 2025: € 292,673 ▲ 34% vs 2024 (€ 219,019) Unchanged	▲ 34%

Key figures of Dokter Charlotte Smetcoren, Neurologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dokter Charlotte Smetcoren, Neurologie?

What happened at Dokter Charlotte Smetcoren, Neurologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 25, 2026 New annual accounts for financial year 2025: profit of € 188,084 (▲ 101% vs 2024). filed late Source: NBB ↗
Sep 25, 2019 New establishment in Beersel. KBO
2019 Charlotte Smetcoren became a director. NBB
Sep 25, 2019 Start of the company according to the CBE. KBO

In short

From € 71,201 profit in 2022 to € 188,084 profit in 2025.

Paid € 123,119 in corporate taxes since 2022.

Best year ever: 2025, with € 188,084 profit.

Paid out € 332,647 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dokter Charlotte Smetcoren, Neurologie? We notify you, reason included.

Follow Dokter Charlotte Smetcoren, Neurologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Charlotte Smetcoren

Dokter Charlotte Smetcoren, Neurologie

Behind Dokter Charlotte Smetcoren, Neurologie is Charlotte Smetcoren.

See the full network in the app

Directors

According to the 2025 annual accounts

Charlotte Smetcoren

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Bronstraat 37

1652 Beersel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0734.906.642
VAT number: BE 0734.906.642
Registered office: Bronstraat 37, 1652 Beersel
Names & denominations: Dokter Charlotte Smetcoren, Neurologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 September 2019
Peppol: Active · Active since 28 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗